Aviva Bio Revenue
Biotechnology Research • • 1-10 Employees
Aviva Bio revenue & valuation
| Annual revenue | $256,665 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $821,328 |
| Total funding | No funding |
Key Contact at Aviva Bio
Brad Sippy
Co-Founder and Chief Technology Officer
Company overview
| Headquarters | XX |
| Website | |
| NAICS | 541714 |
| Founded | 2025 |
| Employees | 1-10 |
Aviva Bio Email Formats
Aviva Bio uses 1 email format. The most common is {first name}.{last name} (e.g., john.doe@aviva-bio.com), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@aviva-bio.com | 100% |
About Aviva Bio
Aviva Bio is a clinical-stage biotechnology company unlocking the full potential of hormone-based medicine. Through novel drug design and a focus on unmet needs in women’s health, Aviva Bio is developing first-in-class therapeutics to improve lives. Its lead program, AVA-291 (d3-Testosterone), is on track to become the first FDA-approved testosterone therapy designed for women.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Aviva Bio has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
Aviva Bio has never raised funding before.
Canada
United Kingdom
PolandFrequently asked questions
4.8
40,000 users
